Analysis of Reverse Phase Protein Array Data: From Experimental Design towards Targeted Biomarker Discovery
Open Access
Abstract
Mastering the systematic analysis of tumor tissues on a large scale has long been a technical challenge for proteomics. In 2001, reverse phase protein arrays (RPPA) were added to the repertoire of existing immunoassays, which, for the first time, allowed a profiling of minute amounts of tumor lysates even after microdissection. A characteristic feature of RPPA is its outstanding sample capacity permitting the analysis of thousands of samples in parallel as a routine task. Until today, the RPPA approach has matured to a robust and highly sensitive high-throughput platform, which is ideally suited for biomarker discovery. Concomitant with technical advancements, new bioinformatic tools were developed for data normalization and data analysis as outlined in detail in this review. Furthermore, biomarker signatures obtained by different RPPA screens were compared with another or with that obtained by other proteomic formats, if possible. Options for overcoming the downside of RPPA, which is the need to steadily validate new antibody batches, will be discussed. Finally, a debate on using RPPA to advance personalized medicine will conclude this article.Keywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (031A429A, 0316173)
This publication has 49 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Strong EGFR signaling in cell line models of ERBB2-amplified breast cancer attenuates response towards ERBB2-targeting drugsOncogenesis, 2012
- Reno: regularized non-parametric analysis of protein lysate array dataBioinformatics, 2012
- Global microRNA level regulation of EGFR‐driven cell‐cycle protein network in breast cancerMolecular Systems Biology, 2012
- A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast CancersClinical Proteomics, 2010
- Improved reproducibility of reverse‐phase protein microarrays using array microenvironment normalizationProteomics, 2009
- Tissue is alive: New technologies are needed to address the problems of protein biomarker pre‐analytical variabilityProteomics – Clinical Applications, 2009
- Serial dilution curve: a new method for analysis of reverse phase protein array dataBioinformatics, 2009
- RPPAML/RIMS: A metadata format and an information management system for reverse phase protein arraysBMC Bioinformatics, 2008
- Global rank-invariant set normalization (GRSN) to reduce systematic distortions in microarray dataBMC Bioinformatics, 2008